These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20804104)

  • 21. Glomerular proteinuria: a complex interplay between unique players.
    Garg P; Rabelink T
    Adv Chronic Kidney Dis; 2011 Jul; 18(4):233-42. PubMed ID: 21782129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The role of podocyte damage in the pathogenesis of glomerulosclerosis and possible repair mechanisms].
    Ronconi E; Mazzinghi B; Sagrinati C; Angelotti ML; Ballerini L; Parente E; Romagnani P; Lazzeri E; Lasagni L
    G Ital Nefrol; 2009; 26(6):660-9. PubMed ID: 19918748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Focal segmental glomerulosclerosis: recent advances.
    Pollak MR
    Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):138-42. PubMed ID: 18277145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of podocytes in glomerular pathobiology.
    Asanuma K; Mundel P
    Clin Exp Nephrol; 2003 Dec; 7(4):255-9. PubMed ID: 14712353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteinuria: detection and role in native renal disease progression.
    Gorriz JL; Martinez-Castelao A
    Transplant Rev (Orlando); 2012 Jan; 26(1):3-13. PubMed ID: 22137726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Recent developments in genetic kidney diseases].
    Liebau MC; Benzing T
    Dtsch Med Wochenschr; 2011 May; 136(19):1014-20. PubMed ID: 21544793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Foothold of NPHS2 mutations in primary nephrotic syndrome.
    Jaffer AT; Ahmed WU; Raju DS; Jahan P
    J Postgrad Med; 2011; 57(4):314-20. PubMed ID: 22120861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Podocyte biology in human disease.
    de Zoysa JR; Topham PS
    Nephrology (Carlton); 2005 Aug; 10(4):362-7. PubMed ID: 16109083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The spectrum of podocytopathies: a unifying view of glomerular diseases.
    Wiggins RC
    Kidney Int; 2007 Jun; 71(12):1205-14. PubMed ID: 17410103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of B7-1 in proteinuria of glomerular origin.
    Novelli R; Benigni A; Remuzzi G
    Nat Rev Nephrol; 2018 Sep; 14(9):589-596. PubMed ID: 29959373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Podocyte injury and its consequences.
    Nagata M
    Kidney Int; 2016 Jun; 89(6):1221-30. PubMed ID: 27165817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Molecular mechanism of proteinuria caused progression of chronic renal disease].
    Li D; Ding J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Oct; 42(5):608-11. PubMed ID: 20957024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Podocyte injury: the role of proteinuria, urinary plasminogen, and oxidative stress.
    Raij L; Tian R; Wong JS; He JC; Campbell KN
    Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1308-F1317. PubMed ID: 27335373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pathogenic role of Notch activation in podocytes.
    Niranjan T; Murea M; Susztak K
    Nephron Exp Nephrol; 2009; 111(4):e73-9. PubMed ID: 19293596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The pathogenetical mechanisms of glomerular proteinuria.].
    Carraro M; Zennaro C
    G Ital Nefrol; 2006; 23(5):459-70. PubMed ID: 17123259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of cyclosporin A on glomerular barrier function in the nephrotic syndrome.
    Zietse R; Wenting GJ; Kramer P; Schalekamp MA; Weimar W
    Clin Sci (Lond); 1992 Jun; 82(6):641-50. PubMed ID: 1320544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies.
    Eriguchi M; Yotsueda R; Torisu K; Kawai Y; Hasegawa S; Tanaka S; Noguchi H; Masutani K; Kitazono T; Tsuruya K
    Am J Physiol Renal Physiol; 2016 Feb; 310(4):F322-33. PubMed ID: 26632605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pediatric nephrotic syndrome: from the simple to the complex.
    Lane JC; Kaskel FJ
    Semin Nephrol; 2009 Jul; 29(4):389-98. PubMed ID: 19615560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The FERM protein EPB41L5 regulates actomyosin contractility and focal adhesion formation to maintain the kidney filtration barrier.
    Schell C; Rogg M; Suhm M; Helmstädter M; Sellung D; Yasuda-Yamahara M; Kretz O; Küttner V; Suleiman H; Kollipara L; Zahedi RP; Sickmann A; Eimer S; Shaw AS; Kramer-Zucker A; Hirano-Kobayashi M; Abe T; Aizawa S; Grahammer F; Hartleben B; Dengjel J; Huber TB
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):E4621-E4630. PubMed ID: 28536193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis.
    Miura K; Kurihara H; Horita S; Chikamoto H; Hattori M; Harita Y; Tsurumi H; Kajiho Y; Sawada Y; Sasaki S; Igarashi T; Kunishima S; Sekine T
    Nephrol Dial Transplant; 2013 Dec; 28(12):2993-3003. PubMed ID: 24042022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.